TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
615,958
|
556,058
|
587,797 |
| Financial expenses |
6
|
1
|
11 |
| Earnings before taxes |
26,665
|
23,416
|
16,398 |
| EBITDA |
25,584
|
23,174
|
16,631 |
| Total assets |
144,356
|
188,633
|
172,153 |
| Current assets |
142,120
|
186,256
|
169,453 |
| Current liabilities |
27,071
|
82,467
|
67,668 |
| Equity capital |
115,210
|
104,151
|
102,375 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
49
|
48
|
48 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
79.8%
|
55.2%
|
59.5% |
| Turnover per employee |
12,571
|
11,585
|
12,246 |
| Profit as a percentage of turnover |
4.3%
|
4.2%
|
2.8% |
| Return on assets (ROA) |
18.5%
|
12.4%
|
9.5% |
| Current ratio |
525.0%
|
225.9%
|
250.4% |
| Return on equity (ROE) |
23.1%
|
22.5%
|
16.0% |
| Change turnover |
57,037
|
15,873
|
-272 |
| Change turnover % |
10%
|
3%
|
0% |
| Chg. No. of employees |
1
|
0
|
-5 |
| Chg. No. of employees % |
2%
|
0%
|
-9% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.